Shaare-Zedek Mc

Jerusalem 93722

1 studies enrolling now · 6 studies all time

What they study most

Acute Infection, Follicular Lymphoma, Marginal Zone Lymphoma, Multiple Myeloma, PFIC1, PFIC2, Pancreatic Cancer, Progressive Familial Intrahepatic Cholestasis, Sepsis

Studies at this site

• A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
• Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC — Completed
• A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. — Running, not enrolling
• This Study Will Investigate the Efficacy and Safety of A4250 in Children With PFIC Types 1 or 2 — Completed
• A Multicenter Prospective Observational Study to Derive and Verify the Performance of a Host-response Based Diagnostic Tool for Early Detection of Severe Infections. — Running, not enrolling
• ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study — Completed